All Comments by

  1. Benjamin Wolozin on Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischaemia.
  2. Benjamin Wolozin on Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes.
  3. Benjamin Wolozin on A loss of function mutant of the presenilin homologue SEL-12 undergoes aberrant endoproteolysis in Caenorhabditis elegans and increases abeta 42 generation in human cells.
  4. Benjamin Wolozin on Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production.
  5. Benjamin Wolozin on Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.
  6. Benjamin Wolozin on Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation.
  7. John Hardy on Reduction of Abeta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin.
  8. Benjamin Wolozin on Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice.
  9. Benjamin Wolozin on Cholesterol-dependent modulation of tau phosphorylation in cultured neurons.
  10. John Hardy on Growth arrest of individual senile plaques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy.
  11. Edward Koo on Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice.
  12. Edward Koo on Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.
  13. Benjamin Wolozin on Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.
  14. Benjamin Wolozin on Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.
  15. John Hardy on Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation.